HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Goggins Selected Research

Pancreatic Cyst

1/2022Alterations in the Duodenal Fluid Microbiome of Patients With Pancreatic Cancer.
1/2017A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts.
10/2016Cyst Fluid Telomerase Activity Predicts the Histologic Grade of Cystic Neoplasms of the Pancreas.
7/2016Diffusion-Weighted Magnetic Resonance Imaging in Distinguishing Between Mucin-Producing and Serous Pancreatic Cysts.
5/2015KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound.
4/2015Incremental value of secretin-enhanced magnetic resonance cholangiopancreatography in detecting ductal communication in a population with high prevalence of small pancreatic cysts.
7/2013Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts.
2/2008PGE(2) in pancreatic cyst fluid helps differentiate IPMN from MCN and predict IPMN dysplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Goggins Research Topics

Disease

90Pancreatic Neoplasms (Pancreatic Cancer)
10/2022 - 01/2002
87Neoplasms (Cancer)
10/2022 - 01/2002
60Adenocarcinoma
01/2020 - 01/2002
12Neoplasms, Cystic, Mucinous, and Serous
01/2017 - 04/2003
11Chronic Pancreatitis
08/2017 - 01/2002
8Pancreatitis
01/2022 - 03/2002
8Pancreatic Cyst
01/2022 - 02/2008
8Carcinoma (Carcinomatosis)
12/2019 - 03/2004
5Pancreatic Diseases (Pancreatic Disease)
02/2013 - 03/2002
4Carcinogenesis
12/2015 - 08/2005
4Neoplasm Metastasis (Metastasis)
06/2010 - 01/2002
3Circulating Neoplastic Cells
11/2020 - 02/2014
3Cysts
10/2016 - 07/2013
3Colorectal Neoplasms (Colorectal Cancer)
01/2014 - 06/2005
2Fibrosis (Cirrhosis)
09/2020 - 02/2012
2Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 01/2006
2Breast Neoplasms (Breast Cancer)
06/2019 - 02/2004
2Adenoma (Adenomas)
03/2008 - 07/2004
2Cholecystitis
11/2003 - 04/2003
1Atrophy
10/2022
1Aneuploidy (Aneuploid)
01/2020
1Adenosquamous Carcinoma
12/2019
1Cardiomegaly (Heart Hypertrophy)
06/2019
1Mason-Type Diabetes
06/2019
1Lymphopenia (Lymphocytopenia)
07/2017

Drug/Important Bio-Agent (IBA)

28DNA (Deoxyribonucleic Acid)IBA
11/2020 - 01/2002
25Proteins (Proteins, Gene)FDA Link
01/2020 - 03/2002
17Biomarkers (Surrogate Marker)IBA
01/2020 - 02/2002
12SecretinFDA Link
01/2022 - 01/2003
9RNA (Ribonucleic Acid)IBA
12/2018 - 04/2003
9OligonucleotidesIBA
10/2007 - 08/2003
8Biological ProductsIBA
12/2015 - 08/2003
7DecitabineFDA Link
01/2012 - 02/2003
5AntigensIBA
01/2020 - 07/2003
5Tumor Biomarkers (Tumor Markers)IBA
01/2020 - 04/2002
5MicroRNAs (MicroRNA)IBA
07/2019 - 07/2010
5Histone Deacetylase InhibitorsIBA
05/2014 - 07/2003
5Indicators and Reagents (Reagents)IBA
03/2014 - 05/2002
5Messenger RNA (mRNA)IBA
01/2005 - 08/2003
4EnzymesIBA
01/2022 - 10/2004
4MethyltransferasesIBA
05/2014 - 02/2004
4trichostatin A (A 300)IBA
07/2011 - 07/2003
4OsteopontinIBA
10/2006 - 03/2004
4MesothelinIBA
01/2006 - 07/2003
4Complementary DNA (cDNA)IBA
11/2004 - 04/2002
3Blood Group Antigens (Blood Groups)IBA
01/2019 - 09/2009
3Kazal Pancreatic Trypsin InhibitorIBA
01/2018 - 11/2003
3MucinsIBA
07/2016 - 07/2004
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2008 - 10/2004
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
03/2007 - 01/2002
3hydrogen sulfite (bisulfite)IBA
01/2005 - 01/2002
2CarboxypeptidasesIBA
10/2022 - 01/2018
2Circulating Tumor DNAIBA
01/2020 - 02/2014
2Codon (Codons)IBA
01/2020 - 05/2005
2Hyaluronic Acid (Hyaluronan)IBA
09/2019 - 05/2016
2Keratins (Keratin)IBA
06/2017 - 12/2016
2Small Interfering RNA (siRNA)IBA
05/2017 - 02/2006
2Telomerase (Telomerase Reverse Transcriptase)IBA
10/2016 - 06/2010
2Protein Isoforms (Isoforms)IBA
10/2016 - 03/2007
2N 30IBA
05/2015 - 11/2004
2Vitamin DFDA LinkGeneric
01/2015 - 01/2015
2Histones (Histone)IBA
05/2014 - 07/2005
2Folic Acid (Vitamin M)FDA LinkGeneric
03/2013 - 08/2005
2Monoclonal AntibodiesIBA
02/2013 - 11/2010
2Cadherins (E-Cadherin)IBA
09/2011 - 07/2010
2ParaffinIBA
08/2010 - 05/2002
2AntibodiesIBA
08/2010 - 02/2008
2ProstaglandinsIBA
06/2010 - 02/2008
2lipoprotein-associated coagulation inhibitor (TFPI)IBA
12/2008 - 11/2008
2Cyclin D2IBA
11/2008 - 04/2003
2Growth Differentiation Factor 15IBA
01/2006 - 04/2004
2A-Form DNA (A-DNA)IBA
07/2005 - 08/2003
2Pancreatitis-Associated ProteinsIBA
06/2005 - 03/2002
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
06/2005 - 10/2004
2LigandsIBA
01/2005 - 10/2004
2fascinIBA
07/2004 - 07/2002
2HSP47 Heat-Shock Proteins (Heat Shock Protein 47)IBA
07/2004 - 07/2002
2preproenkephalinIBA
07/2002 - 05/2002
1Carboxypeptidases A (Carboxypeptidase A)IBA
10/2022
118S Ribosomal RNAIBA
01/2022
1Carcinoembryonic AntigenIBA
01/2020
1CarbohydratesIBA
01/2020
1ElementsIBA
01/2020
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
12/2019
1Colloids (Colloid)IBA
12/2019
1Lactic Acid (Lactate)FDA LinkGeneric
11/2019
1ErbB Receptors (EGF Receptor)IBA
06/2019
1Epidermal Growth Factor (EGF)IBA
06/2019
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
06/2019
1Lipase (Acid Lipase)FDA Link
08/2017
1EstersIBA
08/2017

Therapy/Procedure

8Therapeutics
01/2020 - 02/2002
7Pancreaticoduodenectomy
06/2016 - 01/2003
5Lasers (Laser)
02/2012 - 02/2004
4Pancreatectomy
09/2020 - 03/2002
3Aftercare (After-Treatment)
07/2011 - 02/2003
2Radiotherapy
05/2017 - 07/2005
2Neoadjuvant Therapy
01/2016 - 04/2014
2Chemoprevention
01/2016 - 06/2005
1Autologous Transplantation
09/2020